3-Phosphoglyceric Acid

3-Phosphoglyceric Acid

SCHEMBL27483

O=C(O)[C@@H](O)COP(=O)(O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PGK1 P00558 1/20 1.00
PGK2 P07205 1/20 1.00
PGD P52209 3/20 0.63
MPI P34949 1/20 0.47
OR51E2 Q9H255 1/20 0.40
LPAR5 Q9H1C0 2/20 0.39
LPAR6 P43657 1/20 0.39
LPAR1 Q92633 1/20 0.39
LPAR4 Q99677 1/20 0.39
LPAR2 Q9HBW0 1/20 0.39
LPAR3 Q9UBY5 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ENPP2 Q13822 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3-Phosphoglyceric Acid SCHEMBL30428419 1.00 PGK1 (1.00) PGK1PGK2PGDMPIOR51E2
3-Phosphoglyceric Acid SCHEMBL2497743 1.00 PGK1 (1.00) PGK1PGK2PGDMPIOR51E2
3-Phosphoglyceric Acid SCHEMBL27482 1.00 PGK1 (1.00) PGK1PGK2PGDMPIOR51E2
3-Phosphoglyceric Acid SCHEMBL8006738 0.90 PGK1 (0.81) PGK1PGK2PGDMPISMN1; SMN2
SCHEMBL1812894 0.83 PGK1 (0.70) PGK1PGK2PGDLPAR1LPAR3
SCHEMBL21724798 0.82 PGK1 (0.69) PGK1PGK2PGDMPILPAR5
SCHEMBL2510085 0.82 PGK1 (0.69) PGK1PGK2PGDMPILPAR5
SCHEMBL29357297 0.81 PGK1 (0.68) PGK1PGK2PGDMPILPAR5
3-Phosphoglyceric Acid SCHEMBL15019970 0.80 PGK1 (0.64) PGK1PGK2PGD
SCHEMBL704407 0.79 PGK1 (0.65) PGK1PGK2PGDMPILPAR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 890 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4567422-A2 METHODS TO INCREASE SENSITIVITY OF A LC/MS ANALYSIS Waters Technologies Corporation (US) 2025-06-11 EP claimed
US-12306175-B2 Biomarkers for detection and treatment assessment of infectious diseases and disorders ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2025-05-20 US claimed
US-12216034-B2 Methods to increase sensitivity of LC/MS analysis WATERS TECHNOLOGIES CORPORATION (US) 2025-02-04 US claimed
US-20240219275-A1 METHODS TO INCREASE SENSITIVITY OF LC/MS ANALYSIS WATERS TECHNOLOGIES CORPORATION (US) 2024-07-04 US claimed
WO-2024104443-A1 METHOD FOR MODULATING KINASE ACTIVITY AND USE THEREOF 中国科学院分子细胞科学卓越创新中心 2024-05-23 WO claimed
US-20230015215-A1 EVALUATION METHOD OF DIFFERENTIATION STATE OF CELLS, AND CELL CULTURE SYSTEM HITACHI HIGH-TECH CORPORATION (JP) 2023-01-19 US claimed
CN-113341043-B Method for deducing early death and post-death inundation time of corpse in water based on metabonomics marker and application thereof 中国医科大学 2022-11-25 CN claimed
EP-4090964-A1 METHODS TO INCREASE SENSITIVITY LC/MS ANALYSIS Waters Technologies Corporation (US) 2022-11-23 EP claimed
EP-4092129-A1 EVALUATION METHOD OF DIFFERENTIATION STATE OF CELLS, AND CELL CULTURE SYSTEM Hitachi High-Tech Corporation (JP) 2022-11-23 EP claimed
EP-3614141-B1 STABLE URINE INDICATOR WITH LONG-TERM DETECTION AND METHOD FOR ITS PREPARATION AXAGARIUS GMBH & CO KG (DE) 2022-10-05 EP claimed
EP-1895303-B1 METHOD OF ASSAYING 1, 5-ANHYDROGLUCITOL BY USING WHOLE BLOOD NIPPON KAYAKU KK (JP) 2011-05-11 EP claimed
US-7939546-B2 Quinoline derivatives for modulating DNA methylation SUPERGEN, INC. (US) 2011-05-10 US claimed
US-20100075352-A1 Method of assaying bolld component by using whole blood and measurement kit NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2010-03-25 US claimed
US-20090269796-A1 METHODS OF DETECTING AND TREATING MYOCARDIAL ISCHEMIA AND MYOCARDIAL INFARCTION THE GENERAL HOSPITAL CORPORATION (US) 2009-10-29 US claimed
US-20080254508-A1 TYPE I POLYKETIDE SYNTHASE EXTENDER UNITS WISCONSIN ALUMNI RESEARCH FOUNDATION 2008-10-16 US claimed
EP-1895303-A1 METHOD OF ASSAYING BLOOD COMPONENT BY USING WHOLE BLOOD AND MEASUREMENT KIT Nippon Kayaku Kabushiki Kaisha (JP) 2008-03-05 EP claimed
EP-1352627-A2 Reduction of hair growth THE GILLETTE COMPANY (US) 2003-10-15 EP claimed
US-6017721-A CONTACTING SERUM FROM A PATIENT WITH LIGANDS THAT BIND WARM AUTOANTIBODIES BUT DO NOT BIND ALLOANTIBODIES, SEPARATING NON-BOUND SERUM COMPONENTS FROM BOUND WARM AUTOANTIBODIES, USING WARM AUTOANTIBODY-DEPLETED SERUM IN ANTIGLOBIN TESTING THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-01-25 US claimed
EP-0863741-A2 REDUCTION OF HAIR GROWTH HANDELMAN, Joseph H. (US) 1998-09-16 EP claimed
WO-1997019673-A2 REDUCTION OF HAIR GROWTH HANDELMAN, JOSEPH, H. (US) 1997-06-05 WO claimed